The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter Results & Dividend Announcement

23 May 2019 11:41

RNS Number : 0096A
BMO Private Equity Trust PLC
23 May 2019
 

 

To: Stock Exchange

For immediate release:

23 May 2019

 

BMO Private Equity Trust PLC

Quarterly results for the three months to 31 March 2019 (unaudited) 

· Share price total return for the three months of 8.4 per cent for the Ordinary Shares

· NAV total return per Ordinary Share for the three month period ended 31 March 2019 of (0.4) per cent.

· NAV of 381.01p per Ordinary Share.

· Quarterly dividend of 3.73p per Ordinary Share

 

 

Introduction

As at 31 March 2019, the net assets of the Company were £281.7 million, giving a Net Asset Value ("NAV") per share of 381.01p, which taking into account the dividend of 3.58p per share paid on 31 January, gives a decrease of 0.4% over the quarter. The portfolio has gained in value modestly, but this gain was completely offset by currency movements with Euro weakness against Sterling being the principal factor. At 31 March 2019, the Company had net debt of £11.0 million. Outstanding undrawn commitments were £121.2 million, including £18.0m to funds where the investment period has expired.

 

In line with the Company's policy to pay dividends on a quarterly basis, a dividend of 3.65p per share was paid on 30 April 2019 and a further dividend of 3.73p per share will be paid on 31 July 2019 to shareholders on the register on 5 July 2019 and an ex-dividend date of 4 July 2019.

 

New Investments

Three new fund commitments and three new co-investments were made during the quarter. After the quarter end a further two new fund commitments have been made.

 

In the UK £7 million was committed to Kester Capital II, a buy-out fund focusing on the lower mid-market. We are already investors with Kester, an emerging private equity firm, through their first fund and as a co-investor in Jollyes (pet shop chain) and CETA (caravan insurance).

 

€7 million was committed to Silverfleet European Development Fund, a new fund from the well-established firm Silverfleet, which will focus on lower mid-market buy-outs in the size range of enterprise value between €25 million and €75 million across Europe. These are deals which are somewhat below the size bracket usually targeted by Silverfleet and a dedicated team has been created within Silverfleet to implement this extension to their strategy. SEK 40 million (£3.5 million) has been committed to Summa II, a Nordic focused buyout fund focusing on companies where there is a sustainability angle. This follows on from our current investment in Summa's original fund. After the quarter end two commitments were made to Inflexion Supplemental Fund V (£2.7 million) and Inflexion Enterprise Fund V (£6.0 million), updating and adding to this long-standing successful relationship.

 

The new co-investments are diverse by sector and geography. £2.9 million has been invested in San Siro, a funeral services company based in Milan in Northern Italy. The investment is led by Augens, an Italy focused mid-market private equity firm. The investment thesis is centred around expanding from the two initial funeral homes in Milan to establish a small chain in Northern Italy. Unlike in the US, UK or France the funeral services market in Italy is highly fragmented and Augens believe that there is scope to build San Siro into a clear market leader. €3.5 million has been invested in STAXS a Netherlands based supplier of cleanroom consumable products, selling principally to the pharmaceutical sector. The investment is led by the lower mid-market team at Silverfleet, noted above. This company gives exposure to a growing niche market with high barriers to entry and significant scope for internationalisation. Lastly, closer to home for us, £2.1 million has been invested in Unmanned Aerial Vehicle (UAV) company, Cyberhawk. Based in Livingston, near Edinburgh, Cyberhawk has pioneered the use of UAVs to inspect critical energy infrastructure and has a blue-chip customer base in the oil and gas, wind power and utilities sectors. Not only does this allow safer and more efficient inspections of pylons, wind turbines and oil rigs, Cyberhawk delivers inspection results via its proprietary cloud-based asset management software.

 

The component of the portfolio in co-investments is now 42.3%.

 

In the funds element of the portfolio a number of diverse new investments were made during the quarter.

In the Benelux region Bencis called £0.7 million for investment in two companies; Bons & Evers (metal forging) and Medsen - Ceban (pharmacy chain and pill compounding). August Equity IV called £1.0 million for Charterhouse Voice and Data (voice and data communications, hosting and cyber security). In Germany DBAG VII called £0.7 million for investment in KEF (steel and textile cutting machines for making tyres). Apiary Capital called £0.4 million for a platform investment for a childrens' nursery chain in Scotland and North West England.

 

Taking these co-investments and all the drawdowns for the funds together totalled £15.5 million in new investments for the quarter.

 

Realisations

The largest realisation in the quarter was the exit of August Equity II's holding in UK based cyber security company, SecureData. The company was sold after six and half years to French telecoms company Orange SA. This excellent realisation returned £4.0 million with an investment multiple of 7.2x and an IRR of 35%. Argan Capital has continued to sell down its holding in Swedish healthcare company Humana which is listed on the Stockholm Stock Exchange. During the quarter two tranches were sold returning £1.8 million. So far the investment has yielded 5x the original investment. Hutton Collins exited its longstanding investment in restaurant chain Wagamama through the sale to UK listed Restaurant Group. This yielded £0.9 million (2.6x, IRR 17%). Hutton Collins also exited its holding held in both funds I and II in Healthcare at Home through a sale to private equity group Fram. This returned £0.6 million, representing 0.9x cost. Corpfin IV sold Spanish perfume and cosmetics retail chain Arenal to listed Portuguese company Sonae Group. This yielded £0.8 million, which represents 1.8x, with the potential to improve, through earn-outs and escrows, to 2.4x and an IRR of 32%. Herkules III has exited Stamina Group AS (Hjelp 24) a leading occupational health service provider in the Nordic region through a sale to Norvestor. This investment had not achieved its potential and the £0.7 million received represented a return of cost. TDR Capital Fund II, which now only holds companies comprising the modular buildings group Algeco Scotsman continued its realisation process. During the quarter the US remote accommodation section was spun out into a NASDAQ listed vehicle and the fund returned £1.3 million. Lastly from the Italian portfolio of secondary positions £0.7 million was received from the sale by ILP III of Clouditalia, the fibre optic telecoms network. There were a number of other realisations in the quarter with total realisations and associated income coming to £12.8 million.

 

Valuation Changes

The largest positive influence in the quarter was the uplift of specialist software company Dotmatics by £1.9 million. This SEP led investment is making good progress against the original plan. In the US electrical components company Sigma is growing well both organically and through bolt on acquisitions and this is uplifted by £1.7 million. August Equity IV was up by £1.1 million mainly reflecting the exit of SecureData noted above. US Fund Graycliff continues to do well with an uplift of £0.7 million. The Italian portfolio is up by £0.4 million mainly reflecting good progress for furniture company Georgetti. Swiss based adhesive company Schaetti is recovering and is up by £0.6 million.

 

On the negative side cement company Calucem is slightly behind plan and is down by £0.5 million. Astorg IV is down by £0.3 million reflecting a bumpy start to liver diagnostics equipment company Echosens. Warburg Pincus VIII, which has a number of listed shares which have been under pressure, is down by £0.3 million. Our residual holding in Eventbrite, which was received through the exit of Ticketscript, was realised during April once the lock-up period expired. Share price weakness since the year end resulted in a valuation reduction of £2.1m.

 

Financing

As noted above adverse currency movements meant that the progress of the underlying portfolio was offset this quarter. The Company will shortly replace its current borrowing facility with a fresh, larger and somewhat cheaper facility. This will run for five years and provide the Company with plenty of headroom for handling any mismatch of drawdowns and realisations or for securing the acquisition of assets.

 

 

 

 

 

Outlook

At this stage of the year, it appears that the levels of activity within the portfolio are very similar to the same point during 2018. There remains a very active market for private equity exits with many of our partners noting record amounts of 'incoming' interest in their portfolio companies. On the other side of the equation finding attractive deals is, as always, competitive with acquirers having to demonstrate a genuine 'edge' when winning over vendors and management teams. This is usually far more than the mere provision of attractively priced capital. Private equity investment harnesses strategic, and sometimes operational, expertise to capital improving the chance of a target company's success being sustained. Ideally the closer the investor's understanding of a company or sector, the more value they can add and the less they will be required to pay to invest. Private equity firms who take this approach can usually find good deals even when markets are competitive. Much fresh capital has been raised for private equity in recent years, but the increase is not out of line with overall growth in deal value, nor is it surprising given that private equity investment is growing in popularity with institutional and retail investors alike, yet at present represents only a low single figure percentage of all equity investment. There are clearly some 'headwinds' for investment ranging from the UK/EU Brexit Impasse to trade tensions between the US and China, however these are factors which are incorporated by private equity investors into their long term investment plans and certainly do not deter our investment partners from their value creation activities nor should they discourage investors looking to participate in the output from their efforts by gaining exposure to our well diversified portfolio. At this early stage in the year we expect further growth for shareholders.

 

 

 

Hamish Mair

Investment Manager

BMO Investment Business Limited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

three months ended 31 March 2019 (unaudited)

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

Losses on investments held at fair value

-

(1,672)

(1,672)

Exchange gains

-

1,060

1,060

Investment income

634

-

634

Other income

31

-

31

Total income

665

(612)

53

Expenditure

Investment management fee - basic fee

(68)

(619)

(687)

Investment management fee - performance fee

-

-

-

Other expenses

(208)

-

(208)

Total expenditure

(276)

(619)

(895)

Profit/(loss) before finance costs and taxation

389

(1,231)

(842)

Finance costs

(41)

(373)

(414)

Profit/(loss) before taxation

348

(1,604)

(1,256)

Taxation

(66)

66

-

Profit/(loss) for period/total comprehensive income

282

(1,538)

(1,256)

Return per Ordinary Share

0.38p

(2.08)p

(1.70)p

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

three months ended 31 March 2018 (unaudited)

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

Losses on investments held at fair value

-

(2,881)

(2,881)

Exchange gains

-

373

373

Investment income

448

-

448

Other income

24

-

24

Total income

472

(2,508)

(2,036)

Expenditure

Investment management fee - basic fee

(159)

(476)

(635)

Investment management fee - performance fee

-

-

-

Other expenses

(188)

-

(188)

Total expenditure

(347)

(476)

(823)

Profit/(loss) before finance costs and taxation

125

(2,984)

(2,859)

Finance costs

(106)

(319)

(425)

Profit/(loss) before taxation

19

(3,303)

(3,284)

Taxation

(15)

15

-

Profit/(loss) for period/total comprehensive income

4

(3,288)

(3,284)

Return per Ordinary Share

0.01p

(4.45)p

(4.44)p

 

 

 

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Statement of Comprehensive Income for the

year ended 31 December 2018 (audited)

 

 

Revenue

£'000

Capital

£'000

Total

£'000

 

Income

Gains on investments held at fair value

-

36,966

36,966

Exchange gains

-

35

35

Investment income

2,340

-

2,340

Other income

81

-

81

Total income

2,421

37,001

39,422

Expenditure

Investment management fee - basic fee

(660)

(1,980)

(2,640)

Investment management fee - performance fee

-

(2,277)

(2,277)

Other expenses

(760)

-

(760)

Total expenditure

(1,420)

(4,257)

(5,677)

Profit before finance costs and taxation

1,001

32,744

33,745

Finance costs

(428)

(1,286)

(1,714)

Profit before taxation

573

31,458

32,031

Taxation

(109)

109

-

Profit for year/total comprehensive income

464

31,567

32,031

Return per Ordinary Share

0.63p

42.69p

43.32p

 

 

BMO PRIVATE EQUITY TRUST PLC

 

Balance Sheet

 

 

 

As at 31 March 2019

As at 31 March 2018

As at 31 December 2018

(unaudited)

(unaudited)

(audited)

£'000

£'000

 £'000

Non-current assets

Investments at fair value through profit or loss

296,830

259,870

295,242

Current assets

Other receivables

34

304

142

Cash and cash equivalents

14,789

27,893

21,335

14,823

28,197

21,477

Current liabilities

Other payables

(4,126)

(3,799)

(4,267)

Interest-bearing bank loan

(25,799)

-

(26,821)

(29,925)

(3,799)

(31,088)

Net current (liabilities)/assets

(15,102)

24,398

(9,611)

Total assets less current liabilities

281,728

284,268

285,631

 

Non-current liabilities

Interest-bearing bank loan

-

(26,033)

-

Net assets

281,728

258,235

285,631

Equity

Called-up ordinary share capital

739

739

739

Share premium account

2,527

2,527

2,527

Special distributable capital reserve

15,040

15,040

15,040

Special distributable revenue reserve

31,403

31,403

31,403

Capital redemption reserve

1,335

1,335

1,335

Capital reserve

230,684

207,187

234,587

Revenue reserve

-

4

-

Shareholders' funds

281,728

258,235

285,631

Net asset value per Ordinary Share

381.01p

349.24p

386.29p

 

BMO PRIVATE EQUITY TRUST PLC

Reconciliation of Movements in Shareholders' Funds

 

 

 

 

 

Three months ended

31 March

2019

Three months ended

31 March

2018

Year

ended

31 December 2018

 

(unaudited)

(unaudited)

(audited)

 

£'000

£'000

£'000

Opening shareholders' funds

285,631

264,144

264,144

Profit for the period/total

comprehensive income

 

(1,256)

 

(3,284)

 

32,031

Dividends paid

(2,647)

(2,625)

(10,544)

 

Closing shareholders' funds

 

 

281,728

 

258,235

 

285,631

 

 Notes (unaudited)

 

1. The unaudited quarterly results have been prepared on the basis of the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2018. During the year to 31 December 2018, the management fee and bank loan interest were allocated 75 per cent to capital and 25 per cent to revenue. In accordance with the Board's expected long term split of returns in the form of capital gains and income, with effect from 1 January 2019 the allocation basis has been revised to 90 per cent to capital and 10 per cent to revenue.

 

2. Investment management fee:

 

 

 

Three months ended

31 March 2019

(unaudited)

 

 

Three months ended

31 March 2018

(unaudited)

 

 

Year ended

31 December 2018

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Investment management fee - basic fee

 

68

 

619

 

687

 

159

 

476

 

635

 

660

 

1,980

 

2,640

Investment management fee - performance fee

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

2,277

 

2,277

 

 

68

 

619

 

687

 

159

 

476

 

635

 

660

 

4,257

 

4,917

 

 

 

 

 

 

 

 

 

 

 

3. Finance costs:

 

 

 

Three months ended

31 March 2019

(unaudited)

 

 

Three months ended

 31 March 2018

(unaudited)

 

 

Year ended

31 December 2018

(audited)

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

 

 

 

 

 

 

 

 

 

 

Interest payable on bank loans

41

373

414

106

319

425

428

1,286

1,714

 

 

 

 

 

 

 

 

 

 

 

4. Returns and net asset values

 

Three months ended

31 March 2019

(unaudited)

Three months ended

 31 March 2018

(unaudited)

Year ended

31 December 2018

(audited)

The returns and net asset values per share are based on the following figures:

 

 

 

 

Revenue Return

£282,000

£4,000

£464,000

Capital Return

(£1,538,000)

(£3,288,000)

£31,567,000

Net assets attributable to shareholders

£281,728,000

£258,235,000

£285,631,000

Number of shares in issue during the year

73,941,429

73,941,429

73,941,429

Weighted average number of shares in issue during the year

73,941,429

73,941,429

73,941,429

 

 

 

5. The financial information for the three months ended 31 March 2019, which has not been audited or reviewed by the Company's auditor, comprises non-statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2017, on which the auditor issued an unqualified report, have been lodged with the Registrar of Companies. The quarterly report is available on the Company's website www.bmoprivateequitytrust.com

 

Legal Entity Identifier: 2138009FW98WZFCGRN66

 

For more information, please contact:

 

Hamish Mair (Investment Manager)

0131 718 1184

Scott McEllen (Company Secretary)

0131 718 1137

hamish.mair@bmogam.com / scott.mcellen@bmogam.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRFBXLFLKEFXBBQ
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.